Robert Herndon

1.0k total citations
16 papers, 548 citations indexed

About

Robert Herndon is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Robert Herndon has authored 16 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 4 papers in Oncology. Recurrent topics in Robert Herndon's work include Multiple Sclerosis Research Studies (9 papers), Peripheral Neuropathies and Disorders (6 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Robert Herndon is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Peripheral Neuropathies and Disorders (6 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Robert Herndon collaborates with scholars based in United States, Switzerland and Italy. Robert Herndon's co-authors include Douglas Jeffery, Benjamin D. Brooks, Bruce Sigsbee, Justin C. McArthur, Anthony P. Turel, Gary Birnbaum, Howard L. Weiner, Rachel Butler, M Fisher and Matthew Moore and has published in prestigious journals such as The Lancet, Neurology and Journal of Neurochemistry.

In The Last Decade

Robert Herndon

16 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Herndon United States 11 433 199 166 142 91 16 548
M. S. Freedman Canada 9 411 0.9× 177 0.9× 108 0.7× 132 0.9× 105 1.2× 16 536
Lynn Stazzone United States 9 431 1.0× 152 0.8× 91 0.5× 75 0.5× 81 0.9× 10 530
Aaron E. Miller United States 10 381 0.9× 145 0.7× 117 0.7× 111 0.8× 151 1.7× 18 656
Emmanuelle Leray France 6 483 1.1× 210 1.1× 139 0.8× 155 1.1× 77 0.8× 10 572
Claudia Gneiss Austria 15 470 1.1× 176 0.9× 134 0.8× 147 1.0× 172 1.9× 21 672
Brenda Huppke Germany 10 378 0.9× 231 1.2× 86 0.5× 93 0.7× 64 0.7× 13 516
Johannes Lorscheider Switzerland 12 434 1.0× 145 0.7× 127 0.8× 79 0.6× 63 0.7× 28 557
J Richert United States 4 445 1.0× 263 1.3× 61 0.4× 167 1.2× 42 0.5× 5 515
Jeffrey Palmer United States 10 303 0.7× 105 0.5× 132 0.8× 95 0.7× 151 1.7× 28 499
Elisabetta Verdun di Cantogno United States 11 380 0.9× 139 0.7× 93 0.6× 98 0.7× 38 0.4× 23 437

Countries citing papers authored by Robert Herndon

Since Specialization
Citations

This map shows the geographic impact of Robert Herndon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Herndon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Herndon more than expected).

Fields of papers citing papers by Robert Herndon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Herndon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Herndon. The network helps show where Robert Herndon may publish in the future.

Co-authorship network of co-authors of Robert Herndon

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Herndon. A scholar is included among the top collaborators of Robert Herndon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Herndon. Robert Herndon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yoshii, Kazutomo, et al.. (2023). RECO-ASCON: Reconfigurable ASCON hash functions for IoT applications. Integration. 93. 102061–102061. 4 indexed citations
2.
Giovannoni, Gavin, Gary Cutter, Maria Pia Sormani, et al.. (2017). Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses. Multiple Sclerosis and Related Disorders. 12. 70–78. 77 indexed citations
3.
Huang, Juebin, Kimberly S. McDonald, Vettaikorumakankav Vedanarayanan, et al.. (2014). Typical and Atypical Initial Presentations of Neuromyelitis Optica: A Retrospective Study (P4.008). Neurology. 82(10_supplement). 1 indexed citations
4.
Khan, Majid, et al.. (2012). Differentiation of Neuromyelitis Optica from Multiple Sclerosis on Spinal Magnetic Resonance Imaging. International Journal of MS Care. 14(4). 209–214. 23 indexed citations
5.
Cohen, Bruce A., Omar Khan, Douglas Jeffery, et al.. (2004). Identifying and treating patients with suboptimal responses. Neurology. 63(12_suppl_6). S33–40. 46 indexed citations
6.
Jeffery, Douglas & Robert Herndon. (2004). Review of mitoxantrone in the treatment of multiple sclerosis. Neurology. 63(12_suppl_6). S19–24. 22 indexed citations
7.
Herndon, Robert. (2002). Multiple Sclerosis: Immunology, Pathology and Pathophysiology. 21 indexed citations
8.
Jacobs, Lawrence, Donald E. Goodkin, Richard A. Rudick, & Robert Herndon. (1994). Advances in specific therapy for multiple sclerosis. Current Opinion in Neurology. 7(3). 250–254. 12 indexed citations
9.
Sørensen, Per Soelberg, et al.. (1994). Communication Disorders and Dysphagia. Neurorehabilitation and neural repair. 8(3). 137–143. 5 indexed citations
10.
Weiner, Howard L., E. John Orav, David A. Hafler, et al.. (1993). Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis. Neurology. 43(5). 910–910. 192 indexed citations
11.
Rudick, Richard A., Randolph B. Schiffer, & Robert Herndon. (1987). Drug Treatment of Multiple Sclerosis. Seminars in Neurology. 7(2). 150–159. 10 indexed citations
12.
Jacobs, Lawrence, et al.. (1986). MULTICENTRE DOUBLE-BLIND STUDY OF EFFECT OF INTRATHECALLY ADMINISTERED NATURAL HUMAN FIBROBLAST INTERFERON ON EXACERBATIONS OF MULTIPLE SCLEROSIS. The Lancet. 328(8521-8522). 1411–1413. 77 indexed citations
13.
Herndon, Robert. (1985). Pathology and Pathophysiology of Multiple Sclerosis. Seminars in Neurology. 5(2). 99–106. 5 indexed citations
14.
Herndon, Robert & Benjamin D. Brooks. (1985). Misdiagnosis of Multiple Sclerosis. Seminars in Neurology. 5(2). 94–98. 25 indexed citations
15.
Herndon, Robert. (1984). Clinics in Immunology and Allergy, vol 2: Immunoneuropathology. Archives of Neurology. 41(9). 919–919. 1 indexed citations
16.
Herschkowitz, N., et al.. (1969). SYNTHESIS OF SULPHATIDE‐CONTAINING LIPOPROTEINS IN RAT BRAIN1. Journal of Neurochemistry. 16(7). 1049–1057. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. S. Freedman Breakdown of academic impact, for papers by Lynn Stazzone Breakdown of academic impact, for papers by Aaron E. Miller Breakdown of academic impact, for papers by Emmanuelle Leray Breakdown of academic impact, for papers by Claudia Gneiss Breakdown of academic impact, for papers by Brenda Huppke Breakdown of academic impact, for papers by Johannes Lorscheider Breakdown of academic impact, for papers by J Richert Breakdown of academic impact, for papers by Jeffrey Palmer Breakdown of academic impact, for papers by Elisabetta Verdun di Cantogno
Rankless by CCL
2026